Chairholder | Ellen Van Obberghen-Schilling

Ellen Van Obberghen-Schilling is a Research Director at Inserm. She heads the SignaLife LABEX team “Adhesion Signaling and Stromal Reprogramming in the Tumor Microenvironment” at the Institute of Biology Valrose (Inserm-CNRS-UNS). She is scientific coordinator of the iBV Experimental Histopathology facility and co-leader of the Head & Neck Diseases Workpackage of the FHU OncoAge. She focuses her activity on the role of the extracellular matrix (ECM) in carcinoma progression, spread and response to therapy.

Our project will integrate tissue imaging modalities and artificial intelligence-based analysis tools for a deeper understanding and control of cancer, targeting tumor microenvironment and on the role of the extracellular matrix (ECM) in carcinoma progression, spread and response to therapy.